Lindsey G. Thurman
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Lindsey G. Thurman has a total of 25 co-authors. Here are the top co-authors by number of shared publications:
- Alison P. Klein
Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins School of Medicine, Baltimore, USA
1 shared publication - Anthony Mannion
Division of Comparative Medicine, Massachusetts Institute of Technology
1 shared publication Bo Huang
Department of Pathology, The Sol Goldman Pancreatic Cancer Research Center, The Johns Hopkins University School of Medicine, Baltimore, MD, USA; Department of Pathology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
1 shared publication- Cancan Zhou
Department of Hepatobiliary Surgery, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, 710061, China
1 shared publication Christian Gauthier
Department of Pathology, The Sol Goldman Pancreatic Cancer Research Center, The Johns Hopkins University School of Medicine, Baltimore, MD, USA
1 shared publication- Cory Brayton
Johns Hopkins University
1 shared publication
Latest Publications
- Open Access
- 19 June 2026
- Published by Wiley in Journal of Medical Primatology
- Vol. 55 (4) , e70095
Clinical Management of Helicobacter Infection in Captive Baboons ( Papio anubis and Papio hamadryas ), and Isolation and Molecular Characterization of Three Novel Helicobacter Species
Background: Helicobacter spp. are gastric or enterohepatic bacteria that can be commensal, opportunistic, or pathogenic. Few studies have evaluated Helicobacter spp. in baboons. Methods: Twenty‐seven captive baboons were surveyed for Helicobacter spp. by fecal PCR, and a subset evaluated by culture. Nine baboons were treated with oral “triple therapy” with clarithromycin (10 mg/kg), amoxicillin (10 mg/kg), and omeprazole (20 mg) once daily for 10 days. Results: All baboons were positive for Helicobacter spp., including H. macacae (78%), H. suis (19%), and H. pylori (15%). Three novel Helicobacter species were identified by whole genomic sequencing, for which we propose the names Helicobacter papionis , H. simiae , and H. papionifaecis. Treatment was safe and effective for H. pylori , H. suis , and H. macacae , but did not eliminate the novel Helicobacter spp. Conclusions: Species‐specific assays should guide treatment of Helicobacter spp. infections in baboons. Further epidemiologic studies are needed to inform clinical management.
- 19 June 2026
- Published by Wiley in Journal of Medical Primatology
- Vol. 55 (4) , e70095
Open AccessClinical Management of Helicobacter Infection in Captive Baboons ( Papio anubis and Papio hamadryas ), and Isolation and Molecular Characterization of Three Novel Helicobacter Species
Background: Helicobacter spp. are gastric or enterohepatic bacteria that can be commensal, opportunistic, or pathogenic. Few studies have evaluated Helicobacter spp. in baboons. Methods: Twenty‐seven captive baboons were surveyed for Helicobacter spp. by fecal PCR, and a subset evaluated by culture. Nine baboons were treated with oral “triple therapy” with clarithromycin (10 mg/kg), amoxicillin (10 mg/kg), and omeprazole (20 mg) once daily for 10 days. Results: All baboons were positive for Helicobacter spp., including H. macacae (78%), H. suis (19%), and H. pylori (15%). Three novel Helicobacter species were identified by whole genomic sequencing, for which we propose the names Helicobacter papionis , H. simiae , and H. papionifaecis. Treatment was safe and effective for H. pylori , H. suis , and H. macacae , but did not eliminate the novel Helicobacter spp. Conclusions: Species‐specific assays should guide treatment of Helicobacter spp. infections in baboons. Further epidemiologic studies are needed to inform clinical management.
- Open Access
- 28 March 2021
- Published by Elsevier in Pancreatology
- Vol. 21 (5) , 938-941
Examination of ATM, BRCA1, and BRCA2 promoter methylation in patients with pancreatic cancer
- 28 March 2021
- Published by Elsevier in Pancreatology
- Vol. 21 (5) , 938-941
Open AccessExamination of ATM, BRCA1, and BRCA2 promoter methylation in patients with pancreatic cancer